Watanabe T   Sato Y   Masud HMAA   Takayama M   Matsuda H   Hara Y   Yanagi Y   Yoshida M   Goshima F   Murata T   Kimura H   
Cancer gene therapy 27(7-8) 585-598 2019年9月 [査読有り]
Recent developments in therapeutic strategies have improved the prognosis of head and neck squamous cell carcinoma (HNSCC). Nevertheless, 5-year survival rate remains only 40%, necessitating new therapeutic agents. Oncolytic virotherapy entails us...
Tacharoenmuang R   Komoto S   Guntapong R   Upachai S   Singchai P   Ide T   Fukuda S   Ruchusatsawast K   Sriwantana B   Tatsumi M   Motomura K   Takeda N   Murata T   Sangkitporn S   Taniguchi K   Yoshikawa T   
Journal of medical virology 92(2) 174-186 2019年9月 [査読有り]